Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


Abstract submission is open

Submit your abstract

Abstract Submission Deadlines

All abstract submissions for an ESMO Virtual Plenary must be completed by 12:00hrs Swiss time on the dates listed below:

Abstract submission deadline 

Virtual Plenary presentation

Friday, 11 November 2022

Thursday, 15 December 2022

Friday, 13 January 2023

Thursday, 16 February 2023

Friday, 10 February 2023

Monday, 27 March 2023

Friday, 7 April 2023

Thursday, 11 May 2023

Friday, 12 May 2023

Thursday, 15 June 2023

Friday, 9 June 2023

Thursday, 13 July 2023

Friday, 11 August 2023

Thursday, 14 September 2023

Friday, 13 October 2023

Thursday, 16 November 2023

Submission Categories

  • Basic science
  • Biliary tract cancer, incl. cholangiocarcinoma
  • Biomarkers (agnostic)
  • Breast cancer, early stage
  • Breast cancer, locally advanced
  • Breast cancer, metastatic
  • CNS tumours
  • Colorectal cancer
  • Developmental therapeutics
  • Endocrine tumours
  • Germ cell (testicular) cancer and penile cancer
  • Gynaecological cancers
  • Haematological malignancies
  • Head and neck cancer, excluding thyroid
  • Hepatocellular carcinoma (HCC)
  • Investigational immunotherapy
  • Melanoma and other skin tumours
  • Miscellaneous
  • Neuroendocrine tumours
  • New diagnostic tools
  • NSCLC, early stage
  • NSCLC, locally advanced
  • NSCLC, metastatic
  • Oesophagogastric cancer
  • Palliative care
  • Pancreatic cancer
  • Policy and preventive strategies
  • Prostate cancer
  • Psycho-oncology
  • Renal cancer
  • Sarcoma
  • SCLC
  • Supportive care
  • Thoracic malignancies, other
  • Thyroid cancer
  • Translational research (agnostic)
  • Tumour biology and pathology
  • Urothelial cancer

Review and Publication of Accepted Abstracts

Submitted abstracts will be reviewed by the the ESMO Virtual Plenary Review Panel comprising the ESMO President, ESMO President-elect, ESMO Chief Medical Officer, ESMO Congress Scientific Chair(s) and the appropriate Scientific Track Chairs.

Accepted abstracts will be granted an oral presentation by the first author, followed by expert perspectives and an interactive panel and audience discussion / Q&A session.

Presented abstracts will be published in Annals of Oncology as well as on the Annals of Oncology and ESMO websites.

Full abstract regulations are available here

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.